ASHPOfficial American Society of Health-System Pharmacists©

Learn from experts in the field about biosimilars in rheumatology and gastroenterology, biosimilar-related terms such as interchangeability and nocebo effect, and considerations unique to adalimumab biosimilars.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Following pharmacy residency, many new practitioners seek to obtain board certification in a pharmacy specialty to demonstrate their expertise in a defined area of pharmacy practice. In this podcast, board certified pharmacists share practical tips for preparation and maintenance of specialty board certification.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, a student pharmacist and two recent graduates discuss their experiences completing a dual degree PharmD program. Panelists explore areas related to time management, the pros and cons of pursuing dual graduate degrees, and the changing role of pharmacy professionals today. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, three PGY1 pharmacy residents join us to discuss their specialty pharmacy-focused research projects. Topics to be discussed include the impact of pharmacist interventions on treatment outcomes in patients with hepatitis C, the impact of specialty pharmacist interventions in the treatment of multiple sclerosis, and the impact of specialty pharmacy services on medication access for asthma biologics.  
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a  comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Joel Marrs discusses the AJHP Practice Report, “Description of patient questions received by clinical pharmacists in the Nudge Study,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode that features presentations from the 2022 Midyear Clinical Meeting, our content matter experts discuss the ISMP Targeted Medication Safety Best Practices for Community Pharmacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.